theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Hepatology

Hematology   

Questions discussed in this category


Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?
For example, someone needing a higher platelet count for dual antiplatelet agent use after coronary stent placement.
1 Answer available

What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
2 Answers available

Is there benefit to aggressively treating hemochromatosis in a patient who has already progressed to cirrhosis at the time of diagnosis?
1 Answer available
239162371923473


Papers discussed in this category


Archives of internal medicine, 2006 Feb 13
Screening for hemochromatosis in asymptomatic subjects with or without a family history.

Gastroenterology, 2018 May 17
Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

The New England journal of medicine, 2012 Aug 23
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

Related Topics in Hepatology

  • General Hepatology
  • Gastroenterology
  • Metabolic Dysfunction-Associated Liver Diseases
  • Viral Hepatitis
  • Autoimmune Liver Disease
  • Alcohol-associated Liver Disease
  • Genetic Liver Disease
  • Portal Hypertension
  • Liver Tumors
  • Transplant Hepatology

Copyright © 2025 theMednet
All Rights Reserved.